What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.19%Above 5Y avg (0.17%)
Annual Rate
CNY 0.03Paid annual
Payout Ratio
22.9%Sustainable
Last Ex-Dividend
Jul 9, 2026
The reported statements, read against the company's own industry.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
2.41BCNY
361.04M · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
86.11x
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Revenue (TTM)
771.29MCNY
115.59M · vs all stocks (USD)
Updated Oct 22, 2026
Profit Margin
3.64%
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Beta
0.4520x
vs all stocks
Updated Oct 22, 2026
52-Week Change
-21.93%
vs all stocks
Updated Oct 22, 2026
Market Capitalization
2.41BCNY
361.04M · vs all stocks (USD)
Updated Oct 22, 2026
Enterprise Value
2.20BCNY
329.05M · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
86.11x
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Price to Sales (TTM)
3.18x
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Price to Book (MRQ)
2.82x
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Enterprise to Revenue
2.85x
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Enterprise to EBITDA
40.23x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 46.77×.Updated Oct 22, 2026
Gross Margin
31.59%
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Profit Margin
3.64%
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Operating Margin
5.63%
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Return on Assets (TTM)
1.75%
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Return on Equity (TTM)
3.46%
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Revenue (TTM)
771.29MCNY
115.59M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue per Share (TTM)
5.27CNYUpdated Oct 22, 2026
Quarterly Revenue Growth
21.60%
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Gross Profit (TTM)
244.94MCNY
36.71M · vs all stocks (USD)
Updated Oct 22, 2026
EBITDA (TTM)
46.95MCNY
7.04M · vs all stocks (USD)
Updated Oct 22, 2026
Net Income (TTM)
28.06MCNY
4.21M · vs all stocks (USD)
Updated Oct 22, 2026
Quarterly Earnings Growth (YoY)
27.30%
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Operating Cash Flow (TTM)
-21.36MCNY
-3.20M · vs all stocks (USD)
Updated Oct 22, 2026
Levered Free Cash Flow (TTM)
-54.05MCNY
-8.10M · vs all stocks (USD)
Updated Oct 22, 2026
Trailing Annual Dividend Rate
0.0310CNYUpdated Oct 22, 2026
Trailing Annual Dividend Yield
0.19%
vs all stocks
Updated Oct 22, 2026
5-Year Average Dividend Yield
0.17%
vs all stocks
Updated Oct 22, 2026
Payout Ratio
22.94%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 16.32%.Updated Oct 22, 2026
Minority Interest (Equity)
7.11MCNYFY2025 · Dec 31, 2025
Revenue
711.38MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
472.78MCNYFY2025 · Dec 31, 2025
Gross Profit
238.60MCNYFY2025 · Dec 31, 2025
Operating Income
39.37MCNY
5.90M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
28.99MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-272.39KCNYFY2025 · Dec 31, 2025
Net Income
29.26MCNYFY2025 · Dec 31, 2025
EBIT
29.11MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
65.71MCNYFY2025 · Dec 31, 2025
Research & Development
51.59MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
78.13MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
6.96MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
2.00MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
123.83KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1900CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1900CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
146.25MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
146.25MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
29.26MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-1.47MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-51.50MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-66.84MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
175.90MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
29.26MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
1.75MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-56.04MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-26.47MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-15.35MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-313.29MCNYFY2025 · Dec 31, 2025
Sale of Investments
124.53MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-204.10MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
6.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-11.00MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-6.68MCNYFY2025 · Dec 31, 2025
Other Financing Charges
1.78MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-9.90MCNYFY2025 · Dec 31, 2025
Shares Outstanding
150.00MSharesUpdated Oct 22, 2026
Float Shares
60.96MSharesUpdated Oct 22, 2026
% Held by Insiders
62.02%
vs all stocks
Updated Oct 22, 2026
% Held by Institutions
0.43%
vs all stocks
Updated Oct 22, 2026
Total Cash (MRQ)
273.99MCNY
41.06M · vs all stocks (USD)
Updated Oct 22, 2026
Total Cash per Share (MRQ)
1.83CNYUpdated Oct 22, 2026
Total Debt (MRQ)
7.70MCNY
1.15M · vs all stocks (USD)
Updated Oct 22, 2026
Total Debt to Equity (MRQ)
0.0088x
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Current Ratio (MRQ)
2.57x
vs Scientific & Technical Instruments peers
Updated Oct 22, 2026
Book Value per Share (MRQ)
5.80CNYUpdated Oct 22, 2026
Total Assets
1.30BCNY
194.79M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.05BCNYFY2025 · Dec 31, 2025
Total Liabilities
431.71MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
249.98MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.27MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
429.44MCNYFY2025 · Dec 31, 2025
Cash
178.07MCNYFY2025 · Dec 31, 2025
Cash Equivalents
13.37MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
191.43MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
232.27MCNYFY2025 · Dec 31, 2025
Accounts Receivable
434.25MCNYFY2025 · Dec 31, 2025
Inventory
140.74MCNYFY2025 · Dec 31, 2025
Accounts Payable
371.49MCNYFY2025 · Dec 31, 2025
Short-term Debt
4.56MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
4.47MCNYFY2025 · Dec 31, 2025
Long-term Debt
2.02MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
150.00MCNYFY2025 · Dec 31, 2025
Retained Earnings
354.28MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
868.04MCNY
130.09M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
14.93CNYUpdated Oct 22, 2026
52-Week High
25.42CNYUpdated Oct 22, 2026
52-Week Change
-21.93%
vs all stocks
Updated Oct 22, 2026
Beta
0.4520x
vs all stocks
Updated Oct 22, 2026
50-Day MA
18.04CNYUpdated Oct 22, 2026
200-Day MA
19.82CNYUpdated Oct 22, 2026
Avg 10-Day Volume
5.19MSharesUpdated Oct 22, 2026
Avg 30-Day Volume
3.35MSharesUpdated Oct 22, 2026
Diluted EPS (TTM)
0.1900CNYUpdated Oct 22, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
How is this stock valued?
Price Below Mean With Profitability And Book Value
Price sits well below its yearly mean, on three profitable years and rising book value.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.